Skip to main content

Cornerstone Capital, Inc.

Position in LGND — Ligand Pharmaceuticals Inc

CIK 819535 Palo Alto, CA

Position in LGND

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1,568,450
+$600,979 QoQ
Shares Held
7,856
+53.5% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Cornerstone Capital, Inc. holds $5,265,315 across 4 Biotechnology names. LGND ranks #2 (29.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 LGND
Ligand Pharmaceuticals Inc
This page
7,856 $1,568,450

All Filings in LGND

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,568,450 7,856
2025-12-31 $967,471 5,117
2025-09-30 $918,825 5,187
2025-06-30 $652,182 5,737
2025-03-31 $603,188 5,737
2024-12-31 $696,153 6,497
2024-09-30 $650,284 6,497
2024-06-30 $547,437 6,497
2024-03-31 $474,930 6,497
2023-12-31 $496,868 6,957
2023-09-30 $449,639 7,504
2023-06-30 $794,974 11,026
2023-03-31 $994,163 13,515
2022-12-31 $913,156 13,670
2022-09-30 $829,674 15,445
2022-06-30 $859,639 15,445
2022-03-31 $1,083,848 15,445
2021-12-31 $1,360,558 14,120
2021-09-30 $1,283,081 14,763
2021-06-30 $1,208,208 14,763
2021-03-31 $1,404,004 14,763
2020-12-31 $1,524,630 24,575
2020-09-30 $559,848 9,415
2020-06-30 $649,888 9,314
2020-03-31 $464,082 10,230